inibidores da dipeptidil peptidase-iv
Described are novel compounds of the Formula (I), their derivatives, analogs, tautomeric forms, regioisomers, stereoisomers, polymorphs, solvates, intermediates, pharmaceutically acceptable salts, pharmaceutical compositions, metabolites and prodrugs thereof. These compounds are effective in lowerin...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | por |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | JEGANATHA SIVAKUMAR BALASUBRAMANIAN GOPALAN BALASUBRAMANIAN AGNEESWARI RAJALINGAM SHRIDHAR NARAYANAN FRANKLIN POOPPADY SIVANESSAN DHARMALINGAM GAJENDRA SINGH SUKUMAR SAKAMURI JAYANARAYAN KULATHINGAL JEYAMURUGAN MOOKKAN |
description | Described are novel compounds of the Formula (I), their derivatives, analogs, tautomeric forms, regioisomers, stereoisomers, polymorphs, solvates, intermediates, pharmaceutically acceptable salts, pharmaceutical compositions, metabolites and prodrugs thereof. These compounds are effective in lowering blood glucose, serum insulin, free fatty acids, cholesterol, triglyceride levels; treatment of obesity, inflammation, autoimmune diseases such as multiple sclerosis, rheumatoid arthritis; treatment and/or prophylaxis of type II diabetes. These compounds are more particularly dipeptidyl peptidase (DPP IV) inhibitors. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_BRPI1006970A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>BRPI1006970A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_BRPI1006970A23</originalsourceid><addsrcrecordid>eNrjZFDNzMtMykzJL0otVkhJVEjJLEgtKMlMycxRgDASi1N1M8t4GFjTEnOKU3mhNDeDkptriLOHbmpBfnxqcUFicmpeakm8U1CAp6GBgZmluYGjkTFRigCoRygY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>inibidores da dipeptidil peptidase-iv</title><source>esp@cenet</source><creator>JEGANATHA SIVAKUMAR BALASUBRAMANIAN ; GOPALAN BALASUBRAMANIAN ; AGNEESWARI RAJALINGAM ; SHRIDHAR NARAYANAN ; FRANKLIN POOPPADY ; SIVANESSAN DHARMALINGAM ; GAJENDRA SINGH ; SUKUMAR SAKAMURI ; JAYANARAYAN KULATHINGAL ; JEYAMURUGAN MOOKKAN</creator><creatorcontrib>JEGANATHA SIVAKUMAR BALASUBRAMANIAN ; GOPALAN BALASUBRAMANIAN ; AGNEESWARI RAJALINGAM ; SHRIDHAR NARAYANAN ; FRANKLIN POOPPADY ; SIVANESSAN DHARMALINGAM ; GAJENDRA SINGH ; SUKUMAR SAKAMURI ; JAYANARAYAN KULATHINGAL ; JEYAMURUGAN MOOKKAN</creatorcontrib><description>Described are novel compounds of the Formula (I), their derivatives, analogs, tautomeric forms, regioisomers, stereoisomers, polymorphs, solvates, intermediates, pharmaceutically acceptable salts, pharmaceutical compositions, metabolites and prodrugs thereof. These compounds are effective in lowering blood glucose, serum insulin, free fatty acids, cholesterol, triglyceride levels; treatment of obesity, inflammation, autoimmune diseases such as multiple sclerosis, rheumatoid arthritis; treatment and/or prophylaxis of type II diabetes. These compounds are more particularly dipeptidyl peptidase (DPP IV) inhibitors.</description><language>por</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150915&DB=EPODOC&CC=BR&NR=PI1006970A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150915&DB=EPODOC&CC=BR&NR=PI1006970A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JEGANATHA SIVAKUMAR BALASUBRAMANIAN</creatorcontrib><creatorcontrib>GOPALAN BALASUBRAMANIAN</creatorcontrib><creatorcontrib>AGNEESWARI RAJALINGAM</creatorcontrib><creatorcontrib>SHRIDHAR NARAYANAN</creatorcontrib><creatorcontrib>FRANKLIN POOPPADY</creatorcontrib><creatorcontrib>SIVANESSAN DHARMALINGAM</creatorcontrib><creatorcontrib>GAJENDRA SINGH</creatorcontrib><creatorcontrib>SUKUMAR SAKAMURI</creatorcontrib><creatorcontrib>JAYANARAYAN KULATHINGAL</creatorcontrib><creatorcontrib>JEYAMURUGAN MOOKKAN</creatorcontrib><title>inibidores da dipeptidil peptidase-iv</title><description>Described are novel compounds of the Formula (I), their derivatives, analogs, tautomeric forms, regioisomers, stereoisomers, polymorphs, solvates, intermediates, pharmaceutically acceptable salts, pharmaceutical compositions, metabolites and prodrugs thereof. These compounds are effective in lowering blood glucose, serum insulin, free fatty acids, cholesterol, triglyceride levels; treatment of obesity, inflammation, autoimmune diseases such as multiple sclerosis, rheumatoid arthritis; treatment and/or prophylaxis of type II diabetes. These compounds are more particularly dipeptidyl peptidase (DPP IV) inhibitors.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFDNzMtMykzJL0otVkhJVEjJLEgtKMlMycxRgDASi1N1M8t4GFjTEnOKU3mhNDeDkptriLOHbmpBfnxqcUFicmpeakm8U1CAp6GBgZmluYGjkTFRigCoRygY</recordid><startdate>20150915</startdate><enddate>20150915</enddate><creator>JEGANATHA SIVAKUMAR BALASUBRAMANIAN</creator><creator>GOPALAN BALASUBRAMANIAN</creator><creator>AGNEESWARI RAJALINGAM</creator><creator>SHRIDHAR NARAYANAN</creator><creator>FRANKLIN POOPPADY</creator><creator>SIVANESSAN DHARMALINGAM</creator><creator>GAJENDRA SINGH</creator><creator>SUKUMAR SAKAMURI</creator><creator>JAYANARAYAN KULATHINGAL</creator><creator>JEYAMURUGAN MOOKKAN</creator><scope>EVB</scope></search><sort><creationdate>20150915</creationdate><title>inibidores da dipeptidil peptidase-iv</title><author>JEGANATHA SIVAKUMAR BALASUBRAMANIAN ; GOPALAN BALASUBRAMANIAN ; AGNEESWARI RAJALINGAM ; SHRIDHAR NARAYANAN ; FRANKLIN POOPPADY ; SIVANESSAN DHARMALINGAM ; GAJENDRA SINGH ; SUKUMAR SAKAMURI ; JAYANARAYAN KULATHINGAL ; JEYAMURUGAN MOOKKAN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_BRPI1006970A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>por</language><creationdate>2015</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>JEGANATHA SIVAKUMAR BALASUBRAMANIAN</creatorcontrib><creatorcontrib>GOPALAN BALASUBRAMANIAN</creatorcontrib><creatorcontrib>AGNEESWARI RAJALINGAM</creatorcontrib><creatorcontrib>SHRIDHAR NARAYANAN</creatorcontrib><creatorcontrib>FRANKLIN POOPPADY</creatorcontrib><creatorcontrib>SIVANESSAN DHARMALINGAM</creatorcontrib><creatorcontrib>GAJENDRA SINGH</creatorcontrib><creatorcontrib>SUKUMAR SAKAMURI</creatorcontrib><creatorcontrib>JAYANARAYAN KULATHINGAL</creatorcontrib><creatorcontrib>JEYAMURUGAN MOOKKAN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JEGANATHA SIVAKUMAR BALASUBRAMANIAN</au><au>GOPALAN BALASUBRAMANIAN</au><au>AGNEESWARI RAJALINGAM</au><au>SHRIDHAR NARAYANAN</au><au>FRANKLIN POOPPADY</au><au>SIVANESSAN DHARMALINGAM</au><au>GAJENDRA SINGH</au><au>SUKUMAR SAKAMURI</au><au>JAYANARAYAN KULATHINGAL</au><au>JEYAMURUGAN MOOKKAN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>inibidores da dipeptidil peptidase-iv</title><date>2015-09-15</date><risdate>2015</risdate><abstract>Described are novel compounds of the Formula (I), their derivatives, analogs, tautomeric forms, regioisomers, stereoisomers, polymorphs, solvates, intermediates, pharmaceutically acceptable salts, pharmaceutical compositions, metabolites and prodrugs thereof. These compounds are effective in lowering blood glucose, serum insulin, free fatty acids, cholesterol, triglyceride levels; treatment of obesity, inflammation, autoimmune diseases such as multiple sclerosis, rheumatoid arthritis; treatment and/or prophylaxis of type II diabetes. These compounds are more particularly dipeptidyl peptidase (DPP IV) inhibitors.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | por |
recordid | cdi_epo_espacenet_BRPI1006970A2 |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY |
title | inibidores da dipeptidil peptidase-iv |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T19%3A17%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JEGANATHA%20SIVAKUMAR%20BALASUBRAMANIAN&rft.date=2015-09-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EBRPI1006970A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |